Cholinesterase Inhibitors May Not Benefit Mild Cognitive Impairment and Mild Alzheimer Disease Dementia-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cholinesterase Inhibitors May Not Benefit Mild Cognitive Impairment and Mild Alzheimer Disease Dementia

Published:2019-04 Issue:2 Volume:33 Page:87-94
ISSN:0893-0341
Container-title:Alzheimer Disease & Associated Disorders
language:en
Short-container-title:

Author:

Han Jee-young,Besser Lilah M.,Xiong Chengjie,Kukull Walter A.,Morris John C.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Gerontology,Clinical Psychology

Reference38 articles.

1. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer’s disease;Rogers;Neurology,1998

2. A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer’s disease;Farlow;Eur Neurol,2000

3. A 5-month, randomized, placebo-controlled trial of galantamine in AD;Tariot;Neurology,2000

4. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease;Albert;Alzheimers Dement,2011

5. Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial;Salloway;Neurology,2004

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 15 Years of Longitudinal Genetic, Clinical, Cognitive, Imaging, and Biochemical Measures in DIAN;2024-08-09

2. A Holistic Approach to Multimodal Brain Disease Diagnosis in Imbalanced Data;2024 International Conference on Science Technology Engineering and Management (ICSTEM);2024-04-26

3. Brain Age Is Associated with Cognitive Outcomes of Cholinesterase Inhibitor Treatment in Patients with Mild Cognitive Impairment;Journal of Alzheimer's Disease;2024-04-02

4. Detection of Alzheimer's disease using deep learning models: A systematic literature review;Informatics in Medicine Unlocked;2024

5. Type 2 Diabetes Comorbidity and Cognitive Decline in Patients with Alzheimer’s Disease;Journal of Alzheimer's Disease;2023-10-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3